Finance

Lists
PBV:FRA
Prestige Consumer Healthcare Inc
39,40 €
-1,01%
(-0,40) 1D
2 қаз., 08:27:13 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PBV...
Open
39,40 €
High
39,40 €
Low
39,40 €
Mkt. cap
2,12 млрд
Avg. vol.
0,00
Volume
0,00
52-wk high
60,00 €
52-wk low
38,00 €
No. of employees
890
Open
39,40 €
High
39,40 €
Low
39,40 €
Mkt. cap
2,12 млрд
Avg. vol.
0,00
Volume
0,00
52-wk high
60,00 €
52-wk low
38,00 €
No. of employees
890
News stories
From web sources and news partners
The Lufkin Daily News
The Lufkin Daily News
·
21 минут бұрын
Wall St futures gain as yields, oil prices ease ahead of jobs report
Investor's Business Daily
Investor's Business Daily
·
41 минут бұрын
Futures Rise Into Jobs, Tesla; Buy Signal For Micron
Profile
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia. Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano. The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015. Wikipedia
About Prestige Consumer Healthcare Inc
CEOMatthew M. Mannelly
Employees890
Founded1996
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
274,11 млн
283,44 млн
281,62 млн
265,71 млн
Cost of goods sold
120,04 млн
123,63 млн
132,40 млн
123,63 млн
Cost of revenue
120,04 млн
123,63 млн
132,40 млн
123,63 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
66,74 млн
69,73 млн
65,37 млн
77,97 млн
Operating expense
74,40 млн
77,32 млн
73,72 млн
86,72 млн
Total operating expenses
194,44 млн
200,95 млн
206,12 млн
210,35 млн
Operating income
79,67 млн
82,49 млн
75,49 млн
55,36 млн
Other non operating income
-501,00 м.
-10,00 млн
708,00 м.
-34,00 мың
EBT including unusual items
69,13 млн
61,81 млн
64,77 млн
38,54 млн
EBT excluding unusual items
69,13 млн
61,81 млн
64,77 млн
41,38 млн
Income tax expense
26,92 млн
15,12 млн
10,84 млн
9,36 млн
Effective tax rate
38,94%
24,46%
16,74%
24,30%
Other operating expenses
-
-
-
-
Net income
42,21 млн
46,70 млн
53,93 млн
29,18 млн
Net profit margin
15,40%
16,47%
19,15%
10,98%
Earnings per share
0,86
1,14
1,23
0,98
Interest and investment income
-
-
-
-
Interest expense
-10,04 млн
-10,67 млн
-11,43 млн
-13,94 млн
Net interest expenses
-10,04 млн
-10,67 млн
-11,43 млн
-13,94 млн
Depreciation and amortization charges
7,66 млн
7,59 млн
8,35 млн
8,75 млн
EBITDA
87,33 млн
90,08 млн
83,84 млн
64,11 млн
Gain or loss from assets sale
131,00 м.
9,00 мың
25,00 мың
191,00 м.
AI content may include mistakes. Learn more
Google қолданбалары